Medication Safety of Five Oral Chemotherapies: A Proactive Risk Assessment-Reference-Cited by-同舟云学术

Medication Safety of Five Oral Chemotherapies: A Proactive Risk Assessment

Published:2011-01 Issue:1 Volume:7 Page:2-6
ISSN:1554-7477
Container-title:Journal of Oncology Practice
language:en
Short-container-title:JOP

Author:

Weingart Saul N.¹,Spencer Justin¹,Buia Stephanie¹,Duncombe Deborah¹,Singh Prabhjyot¹,Gadkari Mrinalini¹,Connor Maureen¹

Affiliation:

1. Center for Patient Safety, Dana-Farber Cancer Institute, Boston, MA

Abstract

Each stage of the medication process poses risks to the safe use of oral chemotherapies. Failure mode and effects analysis may identify opportunities to improve medication safety and reduce the risk of patient harm.

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Health Policy,Oncology (nursing),Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JOP.2010.000064

Reference10 articles.

1. Oral chemotherapy safety practices at US cancer centres: questionnaire survey

2. Adherence to Therapy With Oral Antineoplastic Agents

3. Celebrating the New

4. Oral outpatient chemotherapy medication errors in children with acute lymphoblastic leukemia

5. Medication Errors Among Adults and Children With Cancer in the Outpatient Setting

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of Failure Mode and Effect Analysis to reduce errors in medication administration in pediatric intensive care units: A quality improvement report;2023-11-07

2. Process mapping in healthcare: a systematic review;BMC Health Services Research;2021-04-14

3. The current situation of handling oral chemotherapy at home for caregivers of pediatric patients with acute leukemia at tumo-hematology department of children’s hospital 2;1ST VAN LANG INTERNATIONAL CONFERENCE ON HERITAGE AND TECHNOLOGY CONFERENCE PROCEEDING, 2021: VanLang-HeriTech, 2021;2021

4. Failure mode and effects analysis for proactive healthcare risk evaluation: A systematic literature review;Journal of Evaluation in Clinical Practice;2019-12-17

5. Handout for research subjects receiving investigational oral chemotherapy;American Journal of Health-System Pharmacy;2019-11-07